Annual ReportHealthcare

GSK plc

GSK.L · Period ending 2025-12-31 · Filed 2025-12-31 · Updated

In short

GSK plc (GSK.L) has revenue up 4.1% to GBP 32.7B and net income up 122.0% to GBP 5.7B year on year. Its net margin is 17.5% and gross margin 72.4%, and it trades at 17.6× trailing earnings. Fisclear flags 1 high-severity risk, led by: Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

1,930p

Market Cap

£75.7B

P/E (TTM)

17.6x

Price ÷ earnings per share

P/B

4.0x

Price ÷ book value

P/S (TTM)

2.3x

Price ÷ revenue per share

Beta

0.28

Low volatility vs market

PEG Ratio

6.2x

P/E ÷ earnings growth rate

52-Week Range

1,690p1,930p now2,282p

4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)

Efficiency
82/100
Value
58/100
Cashflow
65/100
Regime
55/100

ROE 34.9% — exceptional capital return.

Operating margin 25.5% — high profitability.

FCF yield 6.3% — strong cash generation.

Based on filing period ending Dec 2025

International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.

GSK.L vs

🇬🇧 United Kingdom Macro Indicators

Full dashboard →

10-Year Yield

5.24%↑

GBP/USD

1.34→

The 10-year government bond yield is 5.24%; GBP/USD is at 1.3371.

SWOT Analysis — GSK.L

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • EPS (Diluted): GBP 1.39 (+123.2% YoY) — Earnings per share rose 123% — each share earned more.

  • Net Income: GBP 5.7B (+122.0% YoY) — Profit grew 122% — the company kept more of each dollar earned.

  • Operating Cash Flow: GBP 7.7B (+18.1% YoY) — Operating cash flow grew 18% — the business generated more cash from day-to-day operations.

  • Gross Profit: GBP 23.6B (+5.9% YoY) — Gross profit rose 6% — the spread between revenue and direct costs improved.

◈

Weaknesses

No material weaknesses flagged.

◎

Opportunities

  • Revenue: GBP 32.7B (+4.1% YoY) — Revenue grew 4% — the company sold more goods or services than the prior year.

⚠

Threats

  • Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

  • Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.

Year-over-Year Changes

EPS (Diluted)

GBP 1.39

was GBP 0.62

+123.2%

Earnings per share rose 123% — each share earned more.

Net Income

GBP 5.7B

was GBP 2.6B

+122.0%

Profit grew 122% — the company kept more of each dollar earned.

Operating Cash Flow

GBP 7.7B

was GBP 6.6B

+18.1%

Operating cash flow grew 18% — the business generated more cash from day-to-day operations.

Gross Profit

GBP 23.6B

was GBP 22.3B

+5.9%

Gross profit rose 6% — the spread between revenue and direct costs improved.

Revenue

GBP 32.7B

was GBP 31.4B

+4.1%

Revenue grew 4% — the company sold more goods or services than the prior year.

Risk Flags

1 high · 1 medium · 0 low
  • ⚠ High

    Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

  • ◈ Medium

    Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.

Technical Signals

Daily closes · 1-year data

GSK plc: common questions

Is GSK plc profitable?

Yes. GSK plc made a net profit of £5.7B in its latest fiscal year (fiscal 2025), a net margin of 17.5%.

Is GSK plc's revenue growing?

Yes. Revenue grew 4.1% year on year, to GBP 32.7B.

What is GSK plc's P/E ratio?

GSK plc trades at 17.6× its trailing twelve-month earnings. In other words, the share price is about 18 times the profit per share the company earned over the past year.

Does GSK plc pay a dividend?

Yes. GSK plc's forward dividend yield is 3.60%, the expected annual dividend as a share of the current share price.

What are the main risks for GSK plc?

Fisclear's checks flag 2 medium- or high-severity risks. The most serious: Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.

Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — GSK.L

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

Data sourced from London Stock Exchange (LSE), FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.